Pending Trademark Applications Sample Clauses

Pending Trademark Applications. As reflected on Schedule 1, there are as of the date indicated on Schedule 1 fifteen (15) Trademark matters (including both registrations and applications) beneficially owned by Seller for which assignments to Seller have not been recorded. Further, there are sixty-five (65) pending Trademark applications (including 4 of the aforementioned 15 Trademark matters) which have not as yet been registered.
Sample 1
AutoNDA by SimpleDocs
Pending Trademark Applications. COUNTRY TRADEMARK APPLICATION NO. FILING DATE U.S. AURA * 78/431,302 06/07/2004 U.S. SXXXX * 78/446,386 07/06/2004 * Registered owner is Laserscope Corp. EXECUTION VERSION EXHIBIT D
Sample 1
Pending Trademark Applications. Country Serial No. Filing Date Trademark United States TBD EVORAPET Country Serial No. Filing Date Trademark 85/466150 11/07/11 S. rattus JH145 85/466139 11/07/11 S. uberis KJ2 85/466154 11/07/11 S. oralis KJ3 Argentina 3124889 12/09/11 EVORA 3110268 12/09/11 PROBIORA3 Brazil 840014023 02/08/12 EVORAPLUS Filed 02/08/12 PROBIORA3 Canada 1562888 02/22/12 EVORAPET Chile 969767 09/13/11 PROBIORA3 TBA 12/28/11 EVORAPLUS & Design Japan 2011-85965 11/29/11 EVORA 2012-9311 02/21/12 PROBIORA3 & Design Filed EVORAPET Mexico 1210545 09/09/11 EVORA 12115905 09/29/11 PROBIORA3 South Africa 2011/28125 11/04/11 TEDDY’S PRIDE S. Korea 00-0000-00000 03/29/11 PROBIORA3 00-0000-00000 03/29/11 TEDDY’S PRIDE Taiwan 100028484 06/08/11 EVORAPLUS 100028487 06/08/11 EVORAPLUS & Design Venezuela TBA 03/05/12 EVORA 2/30/11 PROBIORA3 Item C. Unfiled Trademarks United States Trademark MU1140 DPOLT LPT3-04 III. Copyrights. None. Exhibit C Form of Warrant THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT, AS AMENDED, OR ANY OTHER APPLICABLE SECURITIES LAWS AND HAVE BEEN ISSUED IN RELIANCE UPON AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND SUCH OTHER SECURITIES LAWS. NEITHER THIS SECURITY NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED, OR OTHERWISE DISPOSED OF, EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED PURSUANT TO A VALID EXEMPTION THEREFROM UNDER THE SECURITIES ACT. Warrant No. Date: WARRANT TO PURCHASE SHARES OF COMMON STOCK OF ORAGENICS, INC. THIS CERTIFIES that, for value received, The Xxxxx Family Limited Partnership is entitled to purchase from Oragenics, Inc., a Florida corporation (the “Corporation”), subject to the terms and conditions hereof, [ ] [( )] shares (the “Warrant Shares”) of common stock, $0.001 par value (the “Common Stock”). This warrant, together with all warrants hereafter issued in exchange or substitution for this warrant, is referred to as the “Warrant” and the holder of this Warrant is referred to as the “Holder.” The Warrant is being issued pursuant to that certain Loan Agreement between the Company and the Purchaser named therein. The number of Warrant Shares is subject to adjustment as hereinafter provided. Notwithstanding anything to the contrary contained herein, this Warrant shall expire an...
Sample 1
Pending Trademark Applications. Country Serial No. Filing Date Trademark United States TBD EVORAPET Country Serial No. Filing Date Trademark 85/466150 11/07/11 S. rattus JH145 85/466139 11/07/11 S. uberis KJ2 85/466154 11/07/11 S. oralis KJ3 Argentina 3124889 12/09/11 EVORA 3110268 12/09/11 PROBIORA3 Brazil 840014023 02/08/12 EVORAPLUS Filed 02/08/12 PROBIORA3 Canada 1562888 02/22/12 EVORAPET Chile 969767 09/13/11 PROBIORA3 TBA 12/28/11 EVORAPLUS & Design Japan 2011-85965 11/29/11 EVORA 2012-9311 02/21/12 PROBIORA3 & Design Filed EVORAPET Mexico 1210545 09/09/11 EVORA 12115905 09/29/11 PROBIORA3 South Africa 2011/28125 11/04/11 TEDDY’S PRIDE S. Korea 00-0000-00000 03/29/11 PROBIORA3 00-0000-00000 03/29/11 TEDDY’S PRIDE Taiwan 100028484 06/08/11 EVORAPLUS 100028487 06/08/11 EVORAPLUS & Design Venezuela TBA 03/05/12 EVORA 2/30/11 PROBIORA3 Item C. Unfiled Trademarks United States Trademark MU1140 DPOLT LPT3-04 III. Copyrights.
Sample 1
Pending Trademark Applications i. Do the to-be-assigned trademark assets include pending trademark applications?
Sample 1
Pending Trademark Applications. Title (Country) Filed Action --------------- ----- ------ VIRAWASH (U.S.A.) 05.04.92 Approved Awaiting Registration
Sample 1
Pending Trademark Applications. In recognition of terms of this Agreement, Xxxxxx agrees at the expense of Hugo Boss to do the following within thirty (30) days of the Effective Date:
Sample 1
AutoNDA by SimpleDocs
Pending Trademark Applications. None. Copyrights Registered Copyrights None. Copyrights Pending Registration Applications None. Material Unregistered Copyrights None. Schedule 5.01(v) Existing Material Contracts Xxxxxx Manufacturing, L.L.C. and Xxxxxx- Europe B.V.: Customer Name Contract Number Amount ($MM) *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** Deltak, L.L.C.: Customer Name Contract Number Amount ($MM) *** *** *** *** *** *** *** *** *** *** *** *** *** *** *** Xxxxxxxx Plant Services, LLC: Customer Name Contract Number Amount ($MM) *** *** *** *** *** *** *** *** *** *** *** *** Xxxxxxxx Specialty Services, LLC: Customer Name Contract Number Amount ($MM) Xxxxxxxx Industrial Services, LLC: Customer Name Contract Number Amount ($MM) *** *** *** *** TEXT OMITTED AND FILED SEPARATELY CONFIDENTIAL TREATMENT REQUESTED Schedule 5.01(z) Existing Commercial Tort Claims None. Schedule 8.01 Existing Liens Entity Lienholder Initial Filing Number Filing Date Nature of Lien Deltak, L.L.C. U.S. Bancorp 21561954 5/28/2002 Equipment Deltak, L.L.C. U.S. Bancorp 21666282 6/06/2002 Equipment Deltak, L.L.C. U.S. Bancorp 41754565 6/14/2004 Lease Deltak, L.L.C. U.S. Bancorp 42496497 9/03/2004 Lease Deltak, L.L.C. U.S. Bancorp 51166959 4/15/2005 Lease Deltak, L.L.C. U.S. Bancorp 52839133 9/14/2005 Lease Xxxxxx Manufacturing, L.L.C. Mitel Capital 50831082 3/16/2005 Equipment2 Xxxxxx Manufacturing, L.L.C. CIT Bank 00000000 9/07/2005 Equipment Xxxxxx Manufacturing, L.L.C. CIT Bank 00000000 11/04/2005 Equipment Xxxxxx Manufacturing, L.L.C. CIT Bank 00000000 12/15/2005 Equipment Contingent right of set-off of Air Liquide (if any) against a refund to the Borrower or any of its Subsidiaries of VAT taxes paid to the Netherlands prior to the date of, and pursuant to, that certain Conditions of Contract dated December 10, 2004 and Completion Agreement dated December 22, 2006 by Maasvlakte Energie BV and Deltak, L.L.C. . Customer Liens on Equipment owned by Deltak, L.L.C. and not extending to the assets of a Credit Party other than Deltak, L.L.C. to any Subsidiary of a Credit Party or to any other assets of Deltak, L.L.C. 2 To be released in accordance with Schedule 4.03. Schedule 8.02 Existing Investments Investor Investee Amount (USD) Global Power Equipment Group Inc. Xxxxxx Power Equipment (Shanghai) Co., Ltd. 200,000 Global Power Equipment Group Inc. Xxxxxx Manufacturing, L.L.C. 14,809,334 Global Power Equipment Group Inc. Deltak, L.L.C. 29,836,668 Global Power Equipment Group Inc. D...
Sample 1
Pending Trademark Applications. App No. Filing Date Xxxx 77/594,820 10/17/2008 LIMBOARD Pending Patent Applications Serial No. Filing Date Title 11/376,894 3/16/2006 METHOD FOR SPECTROPHOTOMETRIC BLOOD OXYGENATION MONITORING 11/914,074 11/09/2007 IMPROVED METHOD FOR SPECTROPHOTOMETRIC BLOOD OXYGENATION MONITORING 12/092,778 5/06/2008 CALIBRATION DEVICE FOR A SPECTROPHOTOMETRIC SYSTEM 12/096,132 6/04/2008 INDICATORS FOR A SPECTROPHOTOMETRIC SYSTEM 12/090,671 4/18/2008 METHOD AND APPARATUS FOR SPECTROPHOTOMETRIC BASED OXIMETRY 12/097,438 6/13/2008 STABILIZED MULTI-WAVELENGTH LASER SYSTEM FOR NON-INVASIVE SPECTROPHOTOMETRIC MONITORING 12/514,955 5/14/2009 APPARATUS FOR SPECTROPHOTOMETRIC BASED OXIMETRY 12/248,556 10/09/2008 NIRS SENSOR MOUNTING APPARATUS 12/574,412 10/06/2009 METHOD AND APPARATUS FOR DETERMINING CEREBRAL DESATURATION IN PATIENTS UNDERGOING 12/607,648 10/28/2009 METHOD AND APPARATUS FOR SPECTROPHOTOMETRIC BASED OXIMETRY OF SPINAL TISSUE 61/224,689 7/10/2009 METHOD FOR SPECTROPHOTOMETRIC BLOOD OXYGENATION MONITORING OF THE LOWER GASTROINTESTINAL TRACT 61/261,563 11/16/2009 METHOD FOR SPECTROPHOTOMETRIC BLOOD OXYGENATION MONITORING OF THE LOWER GASTROINTESTINAL TRACT 61/262,419 11/18/2009 METHOD FOR SPECTROPHOTOMETRIC BLOOD OXYGENATION MONITORING OF THE LOWER GASTROINTESTINAL TRACT 61/306,200 2/19/2010 METHOD FOR SPECTROPHOTOMETRIC BLOOD OXYGENATION MONITORING OF THE LOWER GASTROINTESTINAL TRACT 61/226,161 7/16/2009 IMPLEMENTATION OF DIGITAL SENSOR ID FOR NIRS MONITOR 61/264,080 11/24/2009 METHOD FOR SPECTROPHOTOMETRIC BLOOD OXYGENATION MONITORING Schedule B exceptions SCHEDULE B The National Institutes of Health (NIH), U.S. Department of Health and Human Services (DHHS) has government purposes rights with respect to patents 6,456,862 B2 and 7047054.
Sample 1

Related to Pending Trademark Applications

  • Trademark Use Each party (the “Trademark Party”) grants the other party a worldwide, non-exclusive, non-transferable royalty free limited license (with no right of sublicense) during the term of the Program Terms to use the Trademark Party’s Trademarks solely for the purpose of carrying out the terms of the Business Development Program and as otherwise contemplated by the Program Terms, including but not limited to, the promotion of the Oerings, the parties’ joint eorts and channel programs; provided, that, such Trademarks are used solely in accordance with the Trademark Party’s specifications as to style, color, and typeface, as such specifications may be modified by such party from time to time and communicated to the other party. Partner shall not aix any Wazuh Trademarks to products or services other than the genuine Oerings. Upon notice from the Trademark Party of its objection to any improper or incorrect use of the Trademark Party’s Trademarks, the other party shall correct or stop such usage as soon as reasonably practicable.

  • Patent Applications It is understood by the parties that, pursuant to the Baylor Technology Transfer Agreement, MAS has the initial responsibility for filing, prosecution and maintenance of Patents and Patent Applications covering the Baylor Technology. The parties agree that, as between MAS and CTI, MAS shall be responsible for deciding whether and how to file, prosecute and maintain the Patents and Patent Applications, provided that:

  • Copyright/Trademark/Patent Consultant understands and agrees that all matters produced under this Agreement shall become the property of District and cannot be used without District's express written permission. District shall have all right, title and interest in said matters, including the right to secure and maintain the copyright, trademark and/or patent of said matter in the name of the District. Consultant consents to use of Consultant's name in conjunction with the sale, use, performance and distribution of the matters, for any purpose and in any medium.

  • Patents, Trademarks, Copyrights, Licenses, Etc Each Loan Party and each Subsidiary of each Loan Party owns or possesses all the material patents, trademarks, service marks, trade names, copyrights, licenses, registrations, franchises, permits and rights necessary to own and operate its properties and to carry on its business as presently conducted and planned to be conducted by such Loan Party or Subsidiary, without known possible, alleged or actual conflict with the rights of others.

  • Copyrights, Patents, Trademarks and Licenses, etc The Company and each Subsidiary own or are licensed or otherwise have the right to use all of the material patents, trademarks, service marks, trade names, copyrights, contractual franchises, authorizations and other rights that are reasonably necessary for the operation of their respective businesses, without material conflict with the rights of any other Person. To the best knowledge of the Company, no slogan or other advertising device, product, process, method, substance, part or other material now employed, or now contemplated to be employed, by the Company or any Subsidiary infringes upon any rights held by any other Person. Except as specifically disclosed in Schedule 6.5, no claim or litigation regarding any of the foregoing is pending or, to the knowledge of the Company, threatened, and no patent, invention, device, application, principle or any statute, law, rule, regulation, standard or code is pending or, to the knowledge of the Company, proposed, which, in either case, would reasonably be expected to have a Material Adverse Effect.

  • Patents As to any patentable subject matter contained in the deliverables, the Contractor agrees to disclose such patentable subject matter to the City. Further, if requested by the City, the Contractor agrees to assign and, if necessary, cause each of its employees to assign the entire right, title, and interest to specific inventions under such patentable subject matter to the City and to execute, acknowledge, and deliver and, if necessary, cause each of its employees to execute, acknowledge, and deliver an assignment of letters patent, in a form to be reasonably approved by the City, to the City upon request by the City.

  • Patents and Patent Applications To the Company’s knowledge, all patents and patent applications owned by or licensed to the Company or under which the Company has rights have been duly and properly filed and maintained; to the knowledge of the Company, the parties prosecuting such applications have complied with their duty of candor and disclosure to the USPTO in connection with such applications; and the Company is not aware of any facts required to be disclosed to the USPTO that were not disclosed to the USPTO and which could reasonably be expected to preclude the grant of a patent in connection with any such application or could reasonably be expected to form the basis of a finding of invalidity with respect to any patents that have issued with respect to such applications.

  • Trademarks, Patents Borrower, as of the date hereof, possesses all necessary trademarks, trade names, copyrights, patents, patent rights, and licenses to conduct its business as now operated, without any known conflict with the valid trademarks, trade names, copyrights, patents and license rights of others.

  • Protection and Registration of Intellectual Property Rights (a) (i) Protect, defend and maintain the validity and enforceability of its Intellectual Property; (ii) promptly advise Bank in writing of material infringements of its Intellectual Property; and (iii) not allow any Intellectual Property material to Borrower’s business to be abandoned, forfeited or dedicated to the public without Bank’s written consent.

  • Patents, Trademarks, Etc The Borrower has obtained and holds in full force and effect all patents, trademarks, servicemarks, trade names, copyrights and other such rights, free from burdensome restrictions, which are necessary for the operation of its business as presently conducted, the impairment of which is likely to have a Material Adverse Effect.

Time is Money Join Law Insider Premium to draft better contracts faster.